Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
GEMINI THERAPEUTICSCS INC Share · US36870G1058 · GMTX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GEMINI THERAPEUTICSCS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 16,37 %
Shares Float 3,09 M
Shares Outstanding 18,88 M
Company Profile for GEMINI THERAPEUTICSCS INC Share
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Company Data
Name GEMINI THERAPEUTICSCS INC
Company Gemini Therapeutics, Inc.
Symbol GMTX
Primary Exchange 
NASDAQ
NASDAQ
ISIN US36870G1058
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 25 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 300 One Kendall Square, 02139 Cambridge
IPO Date 2020-08-12
Stock Splits
| Date | Split |
|---|---|
| 30.12.2022 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | GMTX |
More Shares
Investors who hold GEMINI THERAPEUTICSCS INC also have the following shares in their portfolio:
